OPOrasis Pharmaceuticals Team
Orasis Pharmaceuticals
Last updated: February 23, 2026
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical
Sequoia, $30M Series C in 2020
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical
Sequoia, $30M Series C in 2020
- Series C • Sequoia, $30M Series C in 2020
Founder Intelligence Brief: Orasis Pharmaceuticals Team
This profile is built to help readers move from a founder name to decision-ready context. Orasis Pharmaceuticals Team is mapped to Orasis Pharmaceuticals in the Healthcare category, with current stage context as Series C. The primary operating market is Tel Aviv, Israel, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $30.00M, with the latest mapped round as Series C (Sequoia, $30M Series C in 2020). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Series C stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: Israel directory.
- Stage signal: Series C funding coverage.
- Hiring status: No active hiring roles mapped right now.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Orasis Pharmaceuticals Team
Common questions people ask about this profile.
Who is Orasis Pharmaceuticals Team?
Orasis Pharmaceuticals Team is the founder profile listed on 100Xfounder for Orasis Pharmaceuticals, tracked for market signals, company intelligence, and operator-level context.
What does Orasis Pharmaceuticals do?
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical
Where is Orasis Pharmaceuticals based?
Orasis Pharmaceuticals is listed as operating from Tel Aviv, Israel.
What is the current funding stage of Orasis Pharmaceuticals?
Orasis Pharmaceuticals is currently categorized at Series C on 100Xfounder. Funding signal: Sequoia, $30M Series C in 2020
What is the latest funding round for Orasis Pharmaceuticals?
The latest tracked round for Orasis Pharmaceuticals is Series C Sequoia, $30M Series C in 2020. Total tracked rounds: 1.
Is Orasis Pharmaceuticals hiring right now?
Current hiring signal for Orasis Pharmaceuticals: no active hiring signal.
Is Orasis Pharmaceuticals Team's profile verified?
Yes. Orasis Pharmaceuticals Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with Orasis Pharmaceuticals Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.orasis-pharma.com.
What technologies are associated with Orasis Pharmaceuticals?
Orasis Pharmaceuticals is associated with Python, GCP, BigQuery, and React based on current profile intelligence.